Latest study on Europe's ecstasy market reveals new trends in production and trafficking 

Criminal groups in Europe are adapting and expanding MDMA production, refining trafficking methods and extending their reach to new countries and regions. These are among the issues explored in a new analysis — EU Drug Market: MDMA — released today by Europol and the European Union Drugs Agency (EUDA).

The joint analysis from the two EU agencies describes the European market for MDMA (ecstasy), from production and trafficking, to distribution and use. It also details the processes, materials and criminal actors involved at different stages and levels of the market. The findings draw on data and information from Europol’s operational information on serious and organised crime and the EUDA's drug monitoring system.

The EU is central in the global synthetic drugs landscape, with EU-based production serving both domestic and international markets. Around 12.3 million Europeans (aged 15-64) have used MDMA at least once in their lifetime. The European retail MDMA market is estimated to be worth at least EUR 594 million annually, corresponding to around 72.4 million MDMA (ecstasy) tablets consumed in the EU.  (Europol, Den Haag, 27.03.2025)

https://www.europol.europa.eu/media-press/newsroom/news/latest-study-europes-ecstasy-market-reveals-new-trends-in-production-and-trafficking